Clorox said it completed the divestiture of its Better Health Vitamins, Minerals and Supplements (VMS) business in its entirety on September 10, 2024, and the buyer is an affiliate of Piping Rock Health Products, LLC.

8-KRegulation FD DisclosureFiled Sep 10, 2024Period of report Sep 10, 2024Summary published (UTC) Oct 29, 2026

Key points

AI summary

Clorox said it completed the divestiture of its Better Health Vitamins, Minerals and Supplements (VMS) business in its entirety on September 10, 2024, and the buyer is an affiliate of Piping Rock Health Products, LLC.
The company said the divested business includes the Natural Vitality, NeoCell, Rainbow Light and RenewLife brands, related trademarks and licenses, and the manufacturing and distribution facilities in Sunrise, Florida.
The company said the transaction reflects its commitment to keep evolving its portfolio to reduce volatility, accelerate sales growth and structurally improve its margin.
Clorox said it issued a press release on September 10, 2024 under Item 7.01 (Regulation FD Disclosure) of Form 8-K, and it attached the full text of the release as Exhibit 99.1.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Better Health VMS Business Divestiture Completed

Clorox said it completed the divestiture of its Better Health Vitamins, Minerals and Supplements (VMS) business in its entirety on September 10, 2024, and the buyer is an affiliate of Piping Rock Health Products, LLC.

Source · Based on the filing body and exhibits

Brands and Assets Covered by the Divestiture

The company said the divested business includes the Natural Vitality, NeoCell, Rainbow Light and RenewLife brands, related trademarks and licenses, and the manufacturing and distribution facilities in Sunrise, Florida.

Source · Based on the filing body and exhibits

Company's Stated Rationale for the Divestiture

The company said the transaction reflects its commitment to keep evolving its portfolio to reduce volatility, accelerate sales growth and structurally improve its margin.

Source · Based on the filing body and exhibits

Form 8-K Item 7.01 Filing and Attached Press Release

Clorox said it issued a press release on September 10, 2024 under Item 7.01 (Regulation FD Disclosure) of Form 8-K, and it attached the full text of the release as Exhibit 99.1.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.